Symbols / ALKS Stock $33.74 +0.66% Alkermes plc

Healthcare • Drug Manufacturers - Specialty & Generic • Ireland • NMS
ALKS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Fundamentals
Scroll to Statements
Market Cap 5.62B Enterprise Value 5.10B Income 241.66M Sales 1.48B Book/sh 10.99 Cash/sh 3.53
Dividend Yield Payout 0.00% Employees 2050 IPO P/E 23.59 Forward P/E 48.20
PEG 1.96 P/S 3.81 P/B 3.07 P/C EV/EBITDA 18.16 EV/Sales 3.46
Quick Ratio 1.70 Current Ratio 3.55 Debt/Eq 3.85 LT Debt/Eq EPS (ttm) 1.43 EPS next Y 0.70
EPS Growth -67.00% Revenue Growth -10.60% Earnings 2026-05-05 ROA 6.99% ROE 14.72% ROIC
Gross Margin 86.69% Oper. Margin 15.11% Profit Margin 16.37% Shs Outstand 166.25M Shs Float 154.04M Short Float 15.90%
Short Ratio 7.03 Short Interest 52W High 36.48 52W Low 25.17 Beta 0.39 Avg Volume 2.29M
Volume 1.25M Target Price $44.24 Recom Strong_buy Prev Close $33.52 Price $33.74 Change 0.66%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$44.24
Mean price target
2. Current target
$33.74
Latest analyst target
3. DCF / Fair value
$-39.31
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$33.74
Low
$30.00
High
$58.00
Mean
$44.24

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-09 main B of A Securities Neutral → Neutral $36
2026-03-24 main Piper Sandler Overweight → Overweight $43
2026-02-26 main Wells Fargo Overweight → Overweight $43
2026-02-26 main RBC Capital Outperform → Outperform $45
2026-02-24 init Wolfe Research — → Outperform $45
2026-02-20 main B of A Securities Neutral → Neutral $34
2025-11-17 main Truist Securities Buy → Buy $55
2025-11-13 main Wells Fargo Overweight → Overweight $37
2025-11-13 main Deutsche Bank Buy → Buy $45
2025-11-12 reit Truist Securities Buy → Buy $50
2025-11-11 init Truist Securities — → Buy $50
2025-10-29 main Wells Fargo Overweight → Overweight $42
2025-10-29 main Needham Buy → Buy $44
2025-10-27 main Mizuho Outperform → Outperform $45
2025-10-23 reit Piper Sandler Overweight → Overweight $45
2025-10-23 main RBC Capital Outperform → Outperform $47
2025-09-26 up RBC Capital Sector Perform → Outperform $44
2025-09-09 main JP Morgan Neutral → Neutral $35
2025-09-09 reit HC Wainwright & Co. Neutral → Neutral $46
2025-09-03 init Wells Fargo — → Overweight $44
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-10 LURKER NANCY S Director 3,751
2026-04-06 GAFFIN DAVID JOSEPH Officer 2,034 $34.57 $70,315
2026-04-01 HOPKINSON CRAIG C Officer 9,000 $35.51 $319,604
2026-04-01 HOPKINSON CRAIG C Officer 5,000 $19.34 $96,700
2026-03-03 GAFFIN DAVID JOSEPH Officer 4,068 $29.29 $120,108
2026-03-02 PARISI SAMUEL JOSEPH Officer 6,890 $29.29 $201,808
2026-03-02 HOPKINSON CRAIG C Officer 9,000 $29.72 $267,485
2026-03-02 HOPKINSON CRAIG C Officer 5,000 $19.34 $96,700
2026-03-02 NICHOLS CHRISTIAN TODD Officer 6,000 $30.00 $180,000
2026-02-26 JACKSON BLAIR CURTIS Chief Operating Officer 8,322
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,475.90
-5.25%
1,557.63
-6.36%
1,663.40
+49.61%
1,111.80
Operating Revenue
1,475.90
-5.25%
1,557.63
-6.36%
1,663.40
+49.61%
1,111.80
Cost Of Revenue
196.46
-19.92%
245.33
-3.05%
253.04
+16.04%
218.07
Reconciled Cost Of Revenue
169.29
-22.31%
217.90
+1.92%
213.80
+21.09%
176.57
Gross Profit
1,279.44
-2.50%
1,312.30
-6.95%
1,410.37
+57.81%
893.73
Operating Expense
1,025.49
+15.01%
891.66
-10.50%
996.25
+10.72%
899.82
Research And Development
323.96
+32.05%
245.33
-9.41%
270.81
-0.70%
272.70
Selling General And Administration
701.52
+8.72%
645.24
-6.45%
689.75
+16.76%
590.75
Selling And Marketing Expense
480.01
+7.57%
446.21
-8.96%
490.15
+24.97%
392.21
General And Administrative Expense
221.51
+11.30%
199.02
-0.29%
199.60
+0.53%
198.54
Other Gand A
221.51
+11.30%
199.02
-0.29%
199.60
+0.53%
198.54
Total Expenses
1,221.94
+7.47%
1,137.00
-8.99%
1,249.28
+11.75%
1,117.88
Operating Income
253.96
-39.63%
420.64
+1.57%
414.12
+6901.15%
-6.09
Total Operating Income As Reported
253.96
-39.63%
420.64
+1.57%
414.12
+6901.15%
-6.09
EBITDA
330.89
-33.13%
494.86
-4.74%
519.48
+769.07%
59.77
Normalized EBITDA
330.89
-33.13%
494.86
-4.74%
519.48
+537.21%
81.52
Reconciled Depreciation
27.16
-4.79%
28.53
-61.92%
74.93
-3.77%
77.86
EBIT
303.73
-34.87%
466.33
+4.90%
444.55
+2557.71%
-18.09
Total Unusual Items
0.00
0.00
+100.00%
-21.75
Total Unusual Items Excluding Goodwill
0.00
0.00
+100.00%
-21.75
Special Income Charges
0.00
0.00
+100.00%
-21.75
Restructuring And Mergern Acquisition
0.00
0.00
-100.00%
21.75
Net Income
241.66
-34.16%
367.07
+3.18%
355.76
+324.78%
-158.27
Pretax Income
291.45
-34.32%
443.75
+5.27%
421.52
+1454.15%
-31.13
Net Non Operating Interest Income Expense
33.03
+66.20%
19.87
+154.05%
7.82
+244.56%
-5.41
Interest Expense Non Operating
12.28
-45.62%
22.58
-1.97%
23.03
+76.63%
13.04
Net Interest Income
33.03
+66.20%
19.87
+154.05%
7.82
+244.56%
-5.41
Interest Expense
12.28
-45.62%
22.58
-1.97%
23.03
+76.63%
13.04
Interest Income Non Operating
45.30
+6.72%
42.45
+37.58%
30.85
+304.43%
7.63
Interest Income
45.30
+6.72%
42.45
+37.58%
30.85
+304.43%
7.63
Other Income Expense
4.47
+37.79%
3.24
+862.82%
-0.42
+97.83%
-19.63
Other Non Operating Income Expenses
4.47
+37.79%
3.24
+862.82%
-0.42
-120.03%
2.12
Tax Provision
49.79
-30.48%
71.61
+173.34%
-97.64
-4924.01%
2.02
Tax Rate For Calcs
0.00
+6.21%
0.00
-23.33%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
+100.00%
-4.57
Net Income Including Noncontrolling Interests
241.66
-34.16%
367.07
+3.18%
355.76
+324.78%
-158.27
Net Income From Continuing Operation Net Minority Interest
241.66
-35.06%
372.14
-28.32%
519.16
+1665.99%
-33.15
Net Income From Continuing And Discontinued Operation
241.66
-34.16%
367.07
+3.18%
355.76
+324.78%
-158.27
Net Income Continuous Operations
241.66
-35.06%
372.14
-28.32%
519.16
+1665.99%
-33.15
Net Income Discontinuous Operations
0.00
+100.00%
-5.07
+96.90%
-163.40
-30.60%
-125.11
Normalized Income
241.66
-35.06%
372.14
-28.32%
519.16
+3350.93%
-15.97
Net Income Common Stockholders
241.66
-34.16%
367.07
+3.18%
355.76
+324.78%
-158.27
Diluted EPS
1.43
-34.10%
2.17
+3.33%
2.10
+316.49%
-0.97
Basic EPS
1.47
-33.78%
2.22
+3.74%
2.14
+320.62%
-0.97
Basic Average Shares
164.70
-0.42%
165.39
-0.50%
166.22
+1.52%
163.74
Diluted Average Shares
168.74
-0.27%
169.20
-0.31%
169.73
+3.66%
163.74
Diluted NI Availto Com Stockholders
241.66
-34.16%
367.07
+3.18%
355.76
+324.78%
-158.27
Amortization
0.00
-100.00%
1.10
-96.92%
35.69
-1.85%
36.36
Amortization Of Intangibles Income Statement
0.00
-100.00%
1.10
-96.92%
35.69
-1.85%
36.36
Depreciation Amortization Depletion Income Statement
0.00
-100.00%
1.10
-96.92%
35.69
-1.85%
36.36
Depreciation And Amortization In Income Statement
0.00
-100.00%
1.10
-96.92%
35.69
-1.85%
36.36
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,486.99
+20.99%
2,055.57
-3.78%
2,136.22
+8.77%
1,963.98
Current Assets
1,929.16
+36.30%
1,415.36
-4.72%
1,485.51
+31.43%
1,130.31
Cash Cash Equivalents And Short Term Investments
588.22
-21.75%
751.67
-2.82%
773.49
+27.12%
608.47
Cash And Cash Equivalents
388.57
+33.46%
291.15
-36.36%
457.47
+56.41%
292.47
Other Short Term Investments
199.65
-56.65%
460.52
+45.72%
316.02
+0.01%
315.99
Receivables
334.02
-14.25%
389.52
+16.91%
333.18
+12.22%
296.90
Accounts Receivable
268.62
-14.81%
315.33
+37.35%
229.58
+6.20%
216.17
Gross Accounts Receivable
268.62
-14.81%
315.33
+37.35%
229.58
+6.20%
216.17
Allowance For Doubtful Accounts Receivable
-0.20
Receivables Adjustments Allowances
-0.40
-33.33%
-0.30
-50.00%
-0.20
+0.00%
-0.20
Other Receivables
65.80
-11.67%
74.49
-28.24%
103.81
+28.27%
80.93
Inventory
196.62
+7.51%
182.89
-1.89%
186.41
+2.75%
181.42
Raw Materials
68.39
-5.20%
72.14
+1.01%
71.42
+16.95%
61.06
Work In Process
90.50
+13.31%
79.87
+16.02%
68.84
-9.69%
76.23
Finished Goods
37.74
+22.23%
30.88
-33.09%
46.15
+4.58%
44.13
Prepaid Assets
Restricted Cash
731.21
0.00
Assets Held For Sale Current
0.00
-100.00%
94.26
+3955.94%
2.32
Other Current Assets
79.09
-13.36%
91.28
-7.01%
98.17
+138.25%
41.20
Total Non Current Assets
557.83
-12.87%
640.21
-1.61%
650.72
-21.95%
833.67
Net PPE
298.93
-4.13%
311.81
-2.07%
318.40
-0.64%
320.46
Gross PPE
565.94
+0.20%
564.82
+2.96%
548.56
+2.49%
535.22
Accumulated Depreciation
-267.01
-5.53%
-253.01
-9.93%
-230.16
-7.17%
-214.76
Properties
0.00
0.00
0.00
0.00
Land And Improvements
0.96
+0.00%
0.96
+0.00%
0.96
+1.06%
0.95
Buildings And Improvements
150.67
+11.86%
134.70
+1.48%
132.74
+26.82%
104.67
Machinery Furniture Equipment
255.77
+4.78%
244.11
+2.69%
237.73
+6.89%
222.41
Construction In Progress
38.80
-33.56%
58.39
+27.52%
45.79
-41.31%
78.02
Other Properties
77.21
-8.35%
84.25
-7.89%
91.46
-6.23%
97.54
Leases
42.53
+0.28%
42.42
+6.32%
39.89
+26.08%
31.64
Goodwill And Other Intangible Assets
83.84
-0.09%
83.92
-1.30%
85.02
-29.57%
120.71
Goodwill
83.03
+0.00%
83.03
+0.00%
83.03
+0.00%
83.03
Other Intangible Assets
0.81
-8.43%
0.89
-55.30%
1.99
-94.72%
37.68
Investments And Advances
0.14
-99.80%
73.15
+83.39%
39.89
-69.69%
131.61
Non Current Deferred Assets
125.81
-18.74%
154.84
-20.96%
195.89
+70.97%
114.57
Non Current Deferred Taxes Assets
125.81
-18.74%
154.84
-20.96%
195.89
+70.97%
114.57
Other Non Current Assets
49.10
+197.52%
16.50
+43.24%
11.52
-92.13%
146.32
Total Liabilities Net Minority Interest
667.70
+13.06%
590.59
-36.74%
933.54
+1.45%
920.23
Current Liabilities
543.44
+16.82%
465.20
-10.58%
520.22
+4.52%
497.74
Payables And Accrued Expenses
454.24
+17.43%
386.82
-8.14%
421.10
+7.12%
393.12
Payables
107.95
+136.58%
45.63
-30.49%
65.65
+99.89%
32.84
Accounts Payable
107.95
+136.58%
45.63
-30.49%
65.65
+99.89%
32.84
Current Accrued Expenses
346.29
+1.49%
341.19
-4.01%
355.45
-1.34%
360.28
Pensionand Other Post Retirement Benefit Plans Current
82.45
+16.19%
70.96
-14.62%
83.11
+5.09%
79.08
Current Debt And Capital Lease Obligation
6.75
+9.41%
6.17
-29.50%
8.75
-32.09%
12.88
Current Debt
3.00
+0.00%
3.00
Other Current Borrowings
3.00
+0.00%
3.00
Current Capital Lease Obligation
6.75
+9.41%
6.17
+7.31%
5.75
-41.83%
9.88
Current Deferred Liabilities
0.00
-100.00%
1.25
-54.25%
2.73
-59.95%
6.82
Current Deferred Revenue
0.00
-100.00%
1.25
-54.25%
2.73
-59.95%
6.82
Other Current Liabilities
4.54
-22.28%
5.84
Total Non Current Liabilities Net Minority Interest
124.26
-0.90%
125.39
-69.66%
413.32
-2.17%
422.48
Liabilities Heldfor Sale Non Current
0.00
-100.00%
13.54
Long Term Debt And Capital Lease Obligation
63.25
-8.82%
69.37
-80.91%
363.44
-0.85%
366.56
Long Term Debt
287.73
-0.88%
290.27
Long Term Capital Lease Obligation
63.25
-8.82%
69.37
-8.37%
75.71
-0.76%
76.29
Non Current Deferred Liabilities
Non Current Deferred Revenue
Other Non Current Liabilities
61.01
+8.91%
56.02
+12.31%
49.88
+17.68%
42.38
Stockholders Equity
1,819.30
+24.19%
1,464.98
+21.81%
1,202.69
+15.23%
1,043.75
Common Stock Equity
1,819.30
+24.19%
1,464.98
+21.81%
1,202.69
+15.23%
1,043.75
Capital Stock
1.81
+2.43%
1.77
+2.38%
1.73
+2.13%
1.69
Common Stock
1.81
+2.43%
1.77
+2.38%
1.73
+2.13%
1.69
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
181.01
+2.46%
176.67
+2.38%
172.57
+2.14%
168.95
Ordinary Shares Number
165.61
+2.11%
162.18
-2.88%
166.98
+1.58%
164.38
Treasury Shares Number
15.40
+6.28%
14.49
+159.32%
5.59
+22.19%
4.57
Additional Paid In Capital
3,004.67
+5.03%
2,860.89
+4.53%
2,736.93
-6.05%
2,913.10
Retained Earnings
-734.79
+24.75%
-976.46
+27.32%
-1,343.53
+20.94%
-1,699.29
Gains Losses Not Affecting Retained Earnings
-2.10
-6.76%
-1.97
+36.75%
-3.11
+71.44%
-10.89
Treasury Stock
450.29
+7.40%
419.25
+121.43%
189.34
+17.70%
160.86
Other Equity Adjustments
-2.10
-6.76%
-1.97
+36.75%
-3.11
+71.44%
-10.89
Total Equity Gross Minority Interest
1,819.30
+24.19%
1,464.98
+21.81%
1,202.69
+15.23%
1,043.75
Total Capitalization
1,819.30
+24.19%
1,464.98
-1.71%
1,490.42
+11.72%
1,334.02
Working Capital
1,385.72
+45.84%
950.16
-1.57%
965.29
+52.60%
632.56
Invested Capital
1,819.30
+24.19%
1,464.98
-1.90%
1,493.42
+11.70%
1,337.02
Total Debt
70.00
-7.33%
75.54
-79.70%
372.19
-1.91%
379.44
Net Debt
0.80
Capital Lease Obligations
70.00
-7.33%
75.54
-7.26%
81.45
-5.47%
86.17
Net Tangible Assets
1,735.45
+25.66%
1,381.06
+23.57%
1,117.67
+21.08%
923.05
Tangible Book Value
1,735.45
+25.66%
1,381.06
+23.57%
1,117.67
+21.08%
923.05
Available For Sale Securities
73.00
Held To Maturity Securities
0.14
+0.00%
0.14
-99.64%
39.89
-69.69%
131.61
Investmentin Financial Assets
0.14
-99.80%
73.15
+83.39%
39.89
-69.69%
131.61
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
520.75
+18.59%
439.12
+9.41%
401.35
+1807.21%
21.04
Cash Flow From Continuing Operating Activities
520.75
+18.59%
439.12
+9.41%
401.35
+1807.21%
21.04
Net Income From Continuing Operations
241.66
-34.16%
367.07
+3.18%
355.76
+324.78%
-158.27
Depreciation Amortization Depletion
27.16
-4.79%
28.53
-61.92%
74.93
-3.77%
77.86
Depreciation And Amortization
27.16
-4.79%
28.53
-61.92%
74.93
-3.77%
77.86
Other Non Cash Items
5.31
+17.71%
4.51
-28.71%
6.33
-76.80%
27.28
Stock Based Compensation
98.72
+2.15%
96.64
-4.23%
100.91
+7.06%
94.25
Asset Impairment Charge
Deferred Tax
28.77
-28.99%
40.52
+140.56%
-99.90
-204.63%
-32.80
Deferred Income Tax
28.77
-28.99%
40.52
+140.56%
-99.90
-204.63%
-32.80
Operating Gains Losses
Change In Working Capital
119.12
+221.37%
-98.15
-167.71%
-36.66
-388.48%
12.71
Change In Receivables
55.49
+198.50%
-56.34
-55.25%
-36.29
-222.24%
29.68
Changes In Account Receivables
50.50
+197.02%
-52.05
-16.94%
-44.51
-276.28%
25.25
Change In Inventory
-14.06
-554.90%
3.09
+213.97%
-2.71
+91.26%
-31.02
Change In Prepaid Assets
0.85
-62.20%
2.25
+106.47%
-34.85
-554.04%
-5.33
Change In Payables And Accrued Expense
75.57
+253.73%
-49.16
-242.34%
34.53
+13.48%
30.43
Change In Accrued Expense
-25.33
-387.44%
8.81
-23.56%
11.53
-22.64%
14.90
Change In Payable
100.89
+274.05%
-57.97
-351.93%
23.01
+48.12%
15.53
Change In Account Payable
100.89
+274.05%
-57.97
-351.93%
23.01
+48.12%
15.53
Change In Other Working Capital
-1.25
+64.57%
-3.52
+40.52%
-5.93
+16.87%
-7.13
Change In Other Current Assets
7.55
+4.63%
7.21
-53.11%
15.39
-7.13%
16.57
Change In Other Current Liabilities
-5.03
-196.93%
-1.69
+75.15%
-6.81
+66.76%
-20.50
Investing Cash Flow
295.50
+365.48%
-111.31
-308.61%
53.36
+182.67%
-64.54
Cash Flow From Continuing Investing Activities
295.50
+365.48%
-111.31
-308.61%
53.36
+182.67%
-64.54
Net PPE Purchase And Sale
-39.33
-19.11%
-33.02
+30.76%
-47.69
-24.67%
-38.26
Purchase Of PPE
-40.42
-20.71%
-33.48
+30.31%
-48.05
-25.60%
-38.26
Sale Of PPE
1.09
+135.57%
0.46
+30.23%
0.35
0.00
Capital Expenditure
-40.42
-20.71%
-33.48
+30.31%
-48.05
-25.60%
-38.26
Net Investment Purchase And Sale
333.12
+288.99%
-176.26
-274.43%
101.05
+460.33%
-28.04
Purchase Of Investment
-364.37
+25.11%
-486.55
-91.20%
-254.47
+17.83%
-309.67
Sale Of Investment
697.49
+124.79%
310.29
-12.72%
355.52
+26.24%
281.63
Net Business Purchase And Sale
1.71
-98.26%
97.98
0.00
-100.00%
1.76
Purchase Of Business
Net Intangibles Purchase And Sale
0.00
0.00
Purchase Of Intangibles
0.00
0.00
Net Other Investing Changes
1.27
Financing Cash Flow
12.38
+102.51%
-494.14
-70.56%
-289.71
-18306.23%
-1.57
Cash Flow From Continuing Financing Activities
12.38
+102.51%
-494.14
-70.56%
-289.71
-18306.23%
-1.57
Net Issuance Payments Of Debt
0.00
+100.00%
-291.79
-9626.40%
-3.00
+0.00%
-3.00
Issuance Of Debt
0.00
0.00
Repayment Of Debt
0.00
+100.00%
-291.79
-9626.40%
-3.00
+0.00%
-3.00
Long Term Debt Issuance
0.00
0.00
Long Term Debt Payments
0.00
+100.00%
-291.79
-9626.40%
-3.00
+0.00%
-3.00
Net Long Term Debt Issuance
0.00
+100.00%
-291.79
-9626.40%
-3.00
+0.00%
-3.00
Net Common Stock Issuance
0.00
+100.00%
-200.28
0.00
0.00
Common Stock Payments
0.00
+100.00%
-200.28
0.00
0.00
Repurchase Of Capital Stock
0.00
+100.00%
-200.28
0.00
0.00
Proceeds From Stock Option Exercised
43.41
+57.45%
27.57
+64.51%
16.76
-14.62%
19.63
Net Other Financing Charges
-31.03
-4.71%
-29.64
+90.23%
-303.47
-1567.07%
-18.20
Changes In Cash
828.63
+598.21%
-166.32
-200.80%
165.00
+466.08%
-45.07
Beginning Cash Position
291.15
-36.36%
457.47
+56.41%
292.47
-13.35%
337.54
End Cash Position
1,119.78
+284.61%
291.15
-36.36%
457.47
+56.41%
292.47
Free Cash Flow
480.33
+18.41%
405.64
+14.81%
353.31
+2152.79%
-17.21
Interest Paid Supplemental Data
0.00
-100.00%
23.01
+1.15%
22.75
+67.72%
13.56
Income Tax Paid Supplemental Data
5.24
+102.04%
2.59
-94.14%
44.24
+113.23%
20.75
Sale Of Business
1.71
-98.26%
97.98
0.00
-100.00%
1.76
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category